Professor, Psychiatry, UCLA School of Medicine
Psychiatry
Dr. David L. Sultzer, MD
Dr. David L. Sultzer is an expert in the field of Psychiatry. He went to medical school at University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is a one of the best medicals schools. University of North Carolina at Chapel Hill School of Medicine has a rank of 22 in research and a 2 in primary care He received 1 awards: "Super Doctor". Doctor David L. Sultzer, MD is also published. He has 57 publications published. The lastest publication: "Executive dysfunction in Alzheimer's disease: association with neuropsychiatric symptoms and functional impairment.'
Publications
- Brain Structure and Function Related to Depression in Alzheimer's Disease: Contributions from Neuroimaging Research.
- Neurobiology of Delusions, Memory, and Insight in Alzheimer Disease.
- Insight in Alzheimer's disease and its relation to psychiatric and behavioral disturbances.
- Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future.
- Association between cerebral metabolism and Rey-Osterrieth Complex Figure Test performance in Alzheimer's disease.
- Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.
- Effect of second-generation antipsychotics on caregiver burden in alzheimer's disease.
- Cerebral metabolism, cognition, and functional abilities in Alzheimer disease.
- Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD.
- The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes.
- Effect of memantine treatment on regional cortical metabolism in Alzheimer's disease.
- A key step for quality care in psychiatric emergency settings.
- Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.
- Content-specific delusions from right caudate lacunar stroke: association with prefrontal hypometabolism.
- Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
- Anxiety and regional cortical glucose metabolism in patients with Alzheimer's disease.
- Frontal lobe hypometabolism and impaired insight in Alzheimer disease.
- Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease.
- Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.
- Valproate-induced hyperammonemia as a cause of altered mental status.
- Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings.
- Deep brain stimulation of the basolateral amygdala for treatment-refractory combat post-traumatic stress disorder (PTSD): study protocol for a pilot randomized control...
- Susceptibility to atherosclerosis in aortas and coronary arteries of swine with von Willebrand's disease.
- In vivo MR evaluation of age-related increases in brain iron.
- In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.
- A structured trial of risperidone for the treatment of agitation in dementia.
- In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging.
- Screening for dementia: comparison of three commonly used instruments.
- Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease.
- Executive dysfunction in Alzheimer's disease: association with neuropsychiatric symptoms and functional impairment.
- A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia.
- Neuroimaging and the origin of psychiatric symptoms in dementia.
- The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
- A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease.
- p(C) analysis facilitates dementia diagnosis.
- Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings.
- The Neurobehavioral Rating Scale: reliability in patients with dementia.
- Effect of carbon monoxide on atherogenesis in normal pigs and pigs with von Willebrand''s disease.
- Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature.
- Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
- Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale.
- White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study.
- "Life is not worth living": hopelessness in Alzheimer''s disease.
- Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?
- Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
- Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease.
- Psychosis and antipsychotic medications in Alzheimer''s disease: clinical management and research perspectives.
- Effectiveness of atypical antipsychotic drugs in patients with Alzheimer''s disease.
- Memory impairment among primary care veterans.
- Quality indicators for the care of dementia in vulnerable elders.
- The neural correlates of naming and fluency deficits in Alzheimer''s disease: an FDG-PET study.
- Clinical symptom responses to atypical antipsychotic medications in Alzheimer''s disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
- Executive deficits and regional brain metabolism in Alzheimer''s disease.
- Solanezumab for Alzheimer''s disease.
- Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
- Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.
Schools
University of North Carolina At Chapel Hill
University Of California Los Angeles
Procedures Preformed
- Psychiatric Evaluation
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Awards
- Super Doctor
Education
-
UCLA Neuropsychiatric Hospital -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Warden H. Emory, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Paul N. Barkopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elise R. Block, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Merrill T. Sparago, MD |
|
|
Dr. Mafa R. Kamal, MD |
|
|
Dr. Julie M. Pan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angel N. Rendon, MD |
|
|
Dr. Roxy Szeftel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joan F. Scheibel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet J. Schneider, MD |
|
|
Dr. Christine D. Forest, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall Espinoza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodolfo Garcia, MD |
|
|
Dr. Rita A. Suri, MD |
|
|
Dr. Alan J. Coe, MD
This Doctor is OpenDoctor Recommended.
|